Literature DB >> 34972961

Immune System in Action.

Bettzy Stephen1, Joud Hajjar2.   

Abstract

Tumor exists as a complex network of structures with an ability to evolve and evade the host immune surveillance mechanism. The immune milieu which includes macrophages, dendritic cells, natural killer cells, neutrophils, mast cells, B cells, and T cells is found in the core, the invasive margin, or the adjacent stromal or lymphoid component of the tumor. The immune infiltrate is heterogeneous and varies within a patient and between patients of the same tumor histology. The location, density, functionality, and the crosstalk between the immune cells in the tumor microenvironment influence the nature of immune response, prognosis, and treatment outcomes in cancer patients. Therefore, an understanding of the characteristics of the immune cells and their role in tumor immune surveillance is of paramount importance to identify immune targets and to develop novel immune therapeutics in the war against cancer. In this chapter, we provide an overview of the individual components of the human immune system and the translational relevance of predictive biomarkers.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Adaptive; Cancers; Checkpoints; Cytokines; Immune cells; Innate

Mesh:

Year:  2021        PMID: 34972961     DOI: 10.1007/978-3-030-79308-1_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  250 in total

Review 1.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 2.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils.

Authors:  Stephen J Galli; Niels Borregaard; Thomas A Wynn
Journal:  Nat Immunol       Date:  2011-10-19       Impact factor: 25.606

Review 3.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 4.  Dendritic cells: master regulators of the immune response.

Authors:  Ira Mellman
Journal:  Cancer Immunol Res       Date:  2013-09       Impact factor: 11.151

Review 5.  Inflammation and cancer: back to Virchow?

Authors:  F Balkwill; A Mantovani
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

Review 6.  Innate immunity.

Authors:  Stuart E Turvey; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2009-11-24       Impact factor: 10.793

Review 7.  Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.

Authors:  O J Finn
Journal:  Ann Oncol       Date:  2012-09       Impact factor: 32.976

8.  Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

Authors:  Zvi G Fridlender; Jing Sun; Samuel Kim; Veena Kapoor; Guanjun Cheng; Leona Ling; G Scott Worthen; Steven M Albelda
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

9.  Intrinsic mutagenic properties of 5-chlorocytosine: A mechanistic connection between chronic inflammation and cancer.

Authors:  Bogdan I Fedeles; Bret D Freudenthal; Emily Yau; Vipender Singh; Shiou-chi Chang; Deyu Li; James C Delaney; Samuel H Wilson; John M Essigmann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-04       Impact factor: 11.205

Review 10.  The new deal: a potential role for secreted vesicles in innate immunity and tumor progression.

Authors:  Alberto Benito-Martin; Angela Di Giannatale; Sophia Ceder; Héctor Peinado
Journal:  Front Immunol       Date:  2015-02-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.